TipRanks
Sotera Health (DE:SH5)
MUNICH:SH5
Germany Market

Sotera Health (SH5) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

SH5 Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
6 Buy
0 Hold
1 Sell
Based on 7 analysts giving stock ratings to
Sotera
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SH5 Stock 12 Month Forecast

Average Price Target

€20.23
▲(21.12% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Sotera Health in the last 3 months. The average price target is €20.23 with a high forecast of €22.26 and a low forecast of €15.14. The average price target represents a 21.12% change from the last price of €16.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"€11","14":"€14","17":"€17","20":"€20","23":"€23"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":22.26201675,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€22.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.226632361428567,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€20.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.13817139,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€15.14</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,14,17,20,23],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.850924365384614,17.30184873076923,17.752773096153845,18.20369746153846,18.654621826923076,19.105546192307692,19.556470557692307,20.007394923076923,20.45831928846154,20.909243653846154,21.36016801923077,21.811092384615385,{"y":22.26201675,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.694356335494504,16.98871267098901,17.283069006483515,17.57742534197802,17.871781677472526,18.166138012967032,18.460494348461538,18.75485068395604,19.049207019450545,19.34356335494505,19.637919690439556,19.932276025934062,{"y":20.226632361428567,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.4,16.30293626076923,16.20587252153846,16.10880878230769,16.01174504307692,15.914681303846153,15.817617564615384,15.720553825384615,15.623490086153845,15.526426346923076,15.429362607692308,15.332298868461539,15.23523512923077,{"y":15.13817139,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.3,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.4,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€22.26Average Price Target€20.23Lowest Price Target€15.14
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:SH5
Piper Sandler
Piper Sandler
€22.26
Buy
33.31%
Upside
Reiterated
10/19/26
Piper Sandler Sticks to Its Buy Rating for Sotera Health (SHC)
J.P. Morgan Analyst forecast on DE:SH5
J.P. Morgan
J.P. Morgan
€15.14
Sell
-9.35%
Downside
Downgraded
10/14/26
Sotera Health downgraded to Underweight from Neutral at JPMorganSotera Health downgraded to Underweight from Neutral at JPMorgan
Barclays Analyst forecast on DE:SH5
Barclays
Barclays
€19.59
Buy
17.31%
Upside
Reiterated
10/07/26
Barclays Sticks to Its Buy Rating for Sotera Health (SHC)
RBC Capital Analyst forecast on DE:SH5
RBC Capital
RBC Capital
€21.37
Buy
27.97%
Upside
Reiterated
10/06/26
Sotera Health (SHC) Gets a Buy from RBC Capital
Goldman Sachs Analyst forecast on DE:SH5
Goldman Sachs
Goldman Sachs
€21.37
Buy
27.97%
Upside
Reiterated
09/20/26
Goldman Sachs Remains a Buy on Sotera Health (SHC)
Citi
€20.48→€22.26
Buy
33.31%
Upside
Reiterated
08/07/26
Citi Sticks to Its Buy Rating for Sotera Health (SHC)
BMO Capital Analyst forecast on DE:SH5
BMO Capital
BMO Capital
€17.81→€19.59
Buy
17.31%
Upside
Assigned
08/06/26
Sotera Health (SHC) Receives a Buy from BMO Capital
Jefferies Analyst forecast on DE:SH5
Jefferies
Jefferies
€17.36
Buy
3.98%
Upside
Reiterated
11/20/25
Jefferies Keeps Their Buy Rating on Sotera Health (SHC)
KeyBanc
―
Hold
―
Reiterated
11/05/25
Sotera Health (SHC) Receives a Hold from KeyBanc
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:SH5
Piper Sandler
Piper Sandler
€22.26
Buy
33.31%
Upside
Reiterated
10/19/26
Piper Sandler Sticks to Its Buy Rating for Sotera Health (SHC)
J.P. Morgan Analyst forecast on DE:SH5
J.P. Morgan
J.P. Morgan
€15.14
Sell
-9.35%
Downside
Downgraded
10/14/26
Sotera Health downgraded to Underweight from Neutral at JPMorganSotera Health downgraded to Underweight from Neutral at JPMorgan
Barclays Analyst forecast on DE:SH5
Barclays
Barclays
€19.59
Buy
17.31%
Upside
Reiterated
10/07/26
Barclays Sticks to Its Buy Rating for Sotera Health (SHC)
RBC Capital Analyst forecast on DE:SH5
RBC Capital
RBC Capital
€21.37
Buy
27.97%
Upside
Reiterated
10/06/26
Sotera Health (SHC) Gets a Buy from RBC Capital
Goldman Sachs Analyst forecast on DE:SH5
Goldman Sachs
Goldman Sachs
€21.37
Buy
27.97%
Upside
Reiterated
09/20/26
Goldman Sachs Remains a Buy on Sotera Health (SHC)
Citi
€20.48→€22.26
Buy
33.31%
Upside
Reiterated
08/07/26
Citi Sticks to Its Buy Rating for Sotera Health (SHC)
BMO Capital Analyst forecast on DE:SH5
BMO Capital
BMO Capital
€17.81→€19.59
Buy
17.31%
Upside
Assigned
08/06/26
Sotera Health (SHC) Receives a Buy from BMO Capital
Jefferies Analyst forecast on DE:SH5
Jefferies
Jefferies
€17.36
Buy
3.98%
Upside
Reiterated
11/20/25
Jefferies Keeps Their Buy Rating on Sotera Health (SHC)
KeyBanc
―
Hold
―
Reiterated
11/05/25
Sotera Health (SHC) Receives a Hold from KeyBanc
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
KNSAKiniksa Pharmaceuticals
OMCLOmnicell
AXGNAxoGen
ONCBeOne Medicines
AHCOAdaptHealth
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sotera Health

3 Months
David WindleyJefferies
Success Rate
7/12 ratings generated profit
58%
Average Return
+3.96%
Copying David Windley's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +3.96% per trade.
1 Year
David WindleyJefferies
Success Rate
6/12 ratings generated profit
50%
Average Return
+3.33%
Copying David Windley's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.33% per trade.
2 Years
David WindleyJefferies
Success Rate
9/12 ratings generated profit
75%
Average Return
+14.03%
Copying David Windley's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +14.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SH5 Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
3
2
0
0
0
Buy
11
10
11
11
12
Hold
1
1
2
1
1
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
15
13
13
12
14
In the current month, SH5 has received 12 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. SH5 average Analyst price target in the past 3 months is 20.23.
Each month's total comprises the sum of three months' worth of ratings.

SH5 Financial Forecast

SH5 Earnings Forecast

Next quarter’s earnings estimate for SH5 is €0.24 with a range of €0.23 to €0.24. The previous quarter’s EPS was €0.23. SH5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.
Next quarter’s earnings estimate for SH5 is €0.24 with a range of €0.23 to €0.24. The previous quarter’s EPS was €0.23. SH5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.

SH5 Sales Forecast

Next quarter’s sales forecast for SH5 is €284.82M with a range of €282.28M to €289.05M. The previous quarter’s sales results were €286.18M. SH5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.
Next quarter’s sales forecast for SH5 is €284.82M with a range of €282.28M to €289.05M. The previous quarter’s sales results were €286.18M. SH5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.

SH5 Stock Forecast FAQ

What is DE:SH5’s average 12-month price target, according to analysts?
Based on analyst ratings, Sotera Health’s 12-month average price target is 20.23.
    What is DE:SH5’s upside potential, based on the analysts’ average price target?
    Sotera Health has 21.12% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sotera Health a Buy, Sell or Hold?
          Sotera Health has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 0 hold ratings and 1 sell ratings.
            What is Sotera Health’s share price target?
            The average share price target for Sotera Health is 20.23. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €22.26 ,and the lowest forecast is €15.14. The average share price target represents 21.12% Increase from the current price of €16.7.
              What do analysts say about Sotera Health?
              Sotera Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Sotera Health?
                To buy shares of DE:SH5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.